Loading…

Antigenic reactivity of Leishmania (Viannia) lainsoni axenic amastigote proved to be a suitable alternative for optimizing Montenegro skin test

Laboratory diagnosis of American cutaneous leishmaniasis (ACL) requires a tool amenable to the epidemiological status of ACL in Brazil. Montenegro skin test (MST), an efficient immunological tool used for laboratory diagnosis of ACL, induces delayed-type hypersensitivity (DTH) response to the promas...

Full description

Saved in:
Bibliographic Details
Published in:Parasites & vectors 2024-09, Vol.17 (1), p.402-402, Article 402
Main Authors: de Melo, Leonardo Viana, Vasconcelos Dos Santos, Thiago, Ramos, Patrícia Karla, Lima, Luciana Vieira, Campos, Marliane Batista, Silveira, Fernando Tobias
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c484t-b642b5f9b1ba07630c50513c643e2b7a81a794d11b8d32d8b7a883366d23beba3
container_end_page 402
container_issue 1
container_start_page 402
container_title Parasites & vectors
container_volume 17
creator de Melo, Leonardo Viana
Vasconcelos Dos Santos, Thiago
Ramos, Patrícia Karla
Lima, Luciana Vieira
Campos, Marliane Batista
Silveira, Fernando Tobias
description Laboratory diagnosis of American cutaneous leishmaniasis (ACL) requires a tool amenable to the epidemiological status of ACL in Brazil. Montenegro skin test (MST), an efficient immunological tool used for laboratory diagnosis of ACL, induces delayed-type hypersensitivity (DTH) response to the promastigote antigens of Leishmania; however, human immune responses against infection are modulated by the amastigote of the parasite. Leishmania (V.) lainsoni induces strong cellular immunity in humans; therefore, the antigenic reactivity of its axenic amastigote (AMA antigen) to MST was evaluated for the laboratory diagnosis of ACL. Among 70 individuals examined, 60 had a laboratory-confirmed diagnosis of ACL; 53 had localized cutaneous leishmaniasis (LCL), and 7 had mucosal leishmaniasis (ML). Patients were treated at the Evandro Chagas Institute's leishmaniasis clinic, Pará State, Brazil. Ten healthy individuals with no history of ACL (control group) were also examined. Leishmania (V.) braziliensis promastigote antigen (PRO) was used to compare the reactivity with that of AMA antigen. Paired Student's t-test, kappa agreement, and Spearman test were used to evaluate the reactivity of AMA and PRO. The mean reactivity of AMA in ACL patients was 19.4 mm ± 13.3, which was higher (P 
doi_str_mv 10.1186/s13071-024-06486-0
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a0c6d2d7559f419d8edcb3fa10184e0a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A810404697</galeid><doaj_id>oai_doaj_org_article_a0c6d2d7559f419d8edcb3fa10184e0a</doaj_id><sourcerecordid>A810404697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-b642b5f9b1ba07630c50513c643e2b7a81a794d11b8d32d8b7a883366d23beba3</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEoqXwAiyQJTbtIsWOHcdZoVHFz0iDkPjbWteOk7ok9tT2jFpeglfGmSlVR2KBvMjV9XfOVa5PUbwk-JwQwd9EQnFDSlyxEnMmeIkfFcekqXlJKa4fP6iPimcxXmHMcVvzp8URbSllFaXHxe-FS3YwzmoUDOhktzbdIt-jlbHxcgJnAZ3-sOBycYZGsC56ZxHc7CQwQcxynwxaB781HUoeKYMAxY1NoMZcjskEB9nYoN4H5NfJTvaXdQP65F0yzgzBo_jTOpRMTM-LJz2M0by4-54U39-_-3bxsVx9_rC8WKxKzQRLpeKsUnXfKqIAN5xiXeOaUM0ZNZVqQBBoWtYRokRHq07MLUEp511FlVFAT4rl3rfzcCXXwU4QbqUHK3cNHwYJIVk9GglYZ1nX1HXbM9J2wnRa0R4IJoIZPHu93XutN2rKl8alAOOB6eGNs5dy8FtJCKOC4CY7nN45BH-9yWuQk43ajCM44zdRUlJnUHDG_gMluMW84VVGX-_RAfJvWNf7PF3PuFzksQwz3s6zz_9B5dOZyWrvTG9z_0BwdiDQ8zPepAE2Mcrl1y-HbLVndfAxBtPfb4VgOYdY7kMsc4jlLsQSZ9Grh_u8l_xNLf0DeKLtkA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3110906762</pqid></control><display><type>article</type><title>Antigenic reactivity of Leishmania (Viannia) lainsoni axenic amastigote proved to be a suitable alternative for optimizing Montenegro skin test</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>de Melo, Leonardo Viana ; Vasconcelos Dos Santos, Thiago ; Ramos, Patrícia Karla ; Lima, Luciana Vieira ; Campos, Marliane Batista ; Silveira, Fernando Tobias</creator><creatorcontrib>de Melo, Leonardo Viana ; Vasconcelos Dos Santos, Thiago ; Ramos, Patrícia Karla ; Lima, Luciana Vieira ; Campos, Marliane Batista ; Silveira, Fernando Tobias</creatorcontrib><description>Laboratory diagnosis of American cutaneous leishmaniasis (ACL) requires a tool amenable to the epidemiological status of ACL in Brazil. Montenegro skin test (MST), an efficient immunological tool used for laboratory diagnosis of ACL, induces delayed-type hypersensitivity (DTH) response to the promastigote antigens of Leishmania; however, human immune responses against infection are modulated by the amastigote of the parasite. Leishmania (V.) lainsoni induces strong cellular immunity in humans; therefore, the antigenic reactivity of its axenic amastigote (AMA antigen) to MST was evaluated for the laboratory diagnosis of ACL. Among 70 individuals examined, 60 had a laboratory-confirmed diagnosis of ACL; 53 had localized cutaneous leishmaniasis (LCL), and 7 had mucosal leishmaniasis (ML). Patients were treated at the Evandro Chagas Institute's leishmaniasis clinic, Pará State, Brazil. Ten healthy individuals with no history of ACL (control group) were also examined. Leishmania (V.) braziliensis promastigote antigen (PRO) was used to compare the reactivity with that of AMA antigen. Paired Student's t-test, kappa agreement, and Spearman test were used to evaluate the reactivity of AMA and PRO. The mean reactivity of AMA in ACL patients was 19.4 mm ± 13.3, which was higher (P &lt; 0.001) than that of PRO: 12.1 mm ± 8.1. MST reactivity according to the clinical forms revealed that AMA reactivity in LCL and ML, 18.8 mm ± 13.3 and 24.3 mm ± 13.7, was higher (P &lt; 0.001) than that of PRO, 11.8 mm ± 8.2 and 14.6 mm ± 8.4, respectively. AMA reactivity was higher than that of PRO, indicating that AMA is a promising alternative for optimizing MST in the laboratory diagnosis of ACL.</description><identifier>ISSN: 1756-3305</identifier><identifier>EISSN: 1756-3305</identifier><identifier>DOI: 10.1186/s13071-024-06486-0</identifier><identifier>PMID: 39334233</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adult ; Antigen-antibody reactions ; antigens ; Antigens, Protozoan - immunology ; Axenic amastigote antigen ; Axenic promastigote antigen ; Brazil ; cell-mediated immunity ; cutaneous leishmaniasis ; delayed hypersensitivity ; Diagnosis ; Evaluation ; Female ; Humans ; Laboratory diagnosis ; Leishmania ; Leishmania (V.) braziliensis ; Leishmania (V.) lainsoni ; Leishmania - immunology ; Leishmaniasis ; Leishmaniasis, Cutaneous - diagnosis ; Leishmaniasis, Cutaneous - immunology ; Leishmaniasis, Cutaneous - parasitology ; Male ; Methods ; Middle Aged ; Montenegro skin test ; parasites ; Physiological aspects ; Skin tests ; Skin Tests - methods ; t-test ; Young Adult</subject><ispartof>Parasites &amp; vectors, 2024-09, Vol.17 (1), p.402-402, Article 402</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c484t-b642b5f9b1ba07630c50513c643e2b7a81a794d11b8d32d8b7a883366d23beba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438107/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438107/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,37011,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39334233$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Melo, Leonardo Viana</creatorcontrib><creatorcontrib>Vasconcelos Dos Santos, Thiago</creatorcontrib><creatorcontrib>Ramos, Patrícia Karla</creatorcontrib><creatorcontrib>Lima, Luciana Vieira</creatorcontrib><creatorcontrib>Campos, Marliane Batista</creatorcontrib><creatorcontrib>Silveira, Fernando Tobias</creatorcontrib><title>Antigenic reactivity of Leishmania (Viannia) lainsoni axenic amastigote proved to be a suitable alternative for optimizing Montenegro skin test</title><title>Parasites &amp; vectors</title><addtitle>Parasit Vectors</addtitle><description>Laboratory diagnosis of American cutaneous leishmaniasis (ACL) requires a tool amenable to the epidemiological status of ACL in Brazil. Montenegro skin test (MST), an efficient immunological tool used for laboratory diagnosis of ACL, induces delayed-type hypersensitivity (DTH) response to the promastigote antigens of Leishmania; however, human immune responses against infection are modulated by the amastigote of the parasite. Leishmania (V.) lainsoni induces strong cellular immunity in humans; therefore, the antigenic reactivity of its axenic amastigote (AMA antigen) to MST was evaluated for the laboratory diagnosis of ACL. Among 70 individuals examined, 60 had a laboratory-confirmed diagnosis of ACL; 53 had localized cutaneous leishmaniasis (LCL), and 7 had mucosal leishmaniasis (ML). Patients were treated at the Evandro Chagas Institute's leishmaniasis clinic, Pará State, Brazil. Ten healthy individuals with no history of ACL (control group) were also examined. Leishmania (V.) braziliensis promastigote antigen (PRO) was used to compare the reactivity with that of AMA antigen. Paired Student's t-test, kappa agreement, and Spearman test were used to evaluate the reactivity of AMA and PRO. The mean reactivity of AMA in ACL patients was 19.4 mm ± 13.3, which was higher (P &lt; 0.001) than that of PRO: 12.1 mm ± 8.1. MST reactivity according to the clinical forms revealed that AMA reactivity in LCL and ML, 18.8 mm ± 13.3 and 24.3 mm ± 13.7, was higher (P &lt; 0.001) than that of PRO, 11.8 mm ± 8.2 and 14.6 mm ± 8.4, respectively. AMA reactivity was higher than that of PRO, indicating that AMA is a promising alternative for optimizing MST in the laboratory diagnosis of ACL.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antigen-antibody reactions</subject><subject>antigens</subject><subject>Antigens, Protozoan - immunology</subject><subject>Axenic amastigote antigen</subject><subject>Axenic promastigote antigen</subject><subject>Brazil</subject><subject>cell-mediated immunity</subject><subject>cutaneous leishmaniasis</subject><subject>delayed hypersensitivity</subject><subject>Diagnosis</subject><subject>Evaluation</subject><subject>Female</subject><subject>Humans</subject><subject>Laboratory diagnosis</subject><subject>Leishmania</subject><subject>Leishmania (V.) braziliensis</subject><subject>Leishmania (V.) lainsoni</subject><subject>Leishmania - immunology</subject><subject>Leishmaniasis</subject><subject>Leishmaniasis, Cutaneous - diagnosis</subject><subject>Leishmaniasis, Cutaneous - immunology</subject><subject>Leishmaniasis, Cutaneous - parasitology</subject><subject>Male</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Montenegro skin test</subject><subject>parasites</subject><subject>Physiological aspects</subject><subject>Skin tests</subject><subject>Skin Tests - methods</subject><subject>t-test</subject><subject>Young Adult</subject><issn>1756-3305</issn><issn>1756-3305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqNks1u1DAUhSMEoqXwAiyQJTbtIsWOHcdZoVHFz0iDkPjbWteOk7ok9tT2jFpeglfGmSlVR2KBvMjV9XfOVa5PUbwk-JwQwd9EQnFDSlyxEnMmeIkfFcekqXlJKa4fP6iPimcxXmHMcVvzp8URbSllFaXHxe-FS3YwzmoUDOhktzbdIt-jlbHxcgJnAZ3-sOBycYZGsC56ZxHc7CQwQcxynwxaB781HUoeKYMAxY1NoMZcjskEB9nYoN4H5NfJTvaXdQP65F0yzgzBo_jTOpRMTM-LJz2M0by4-54U39-_-3bxsVx9_rC8WKxKzQRLpeKsUnXfKqIAN5xiXeOaUM0ZNZVqQBBoWtYRokRHq07MLUEp511FlVFAT4rl3rfzcCXXwU4QbqUHK3cNHwYJIVk9GglYZ1nX1HXbM9J2wnRa0R4IJoIZPHu93XutN2rKl8alAOOB6eGNs5dy8FtJCKOC4CY7nN45BH-9yWuQk43ajCM44zdRUlJnUHDG_gMluMW84VVGX-_RAfJvWNf7PF3PuFzksQwz3s6zz_9B5dOZyWrvTG9z_0BwdiDQ8zPepAE2Mcrl1y-HbLVndfAxBtPfb4VgOYdY7kMsc4jlLsQSZ9Grh_u8l_xNLf0DeKLtkA</recordid><startdate>20240927</startdate><enddate>20240927</enddate><creator>de Melo, Leonardo Viana</creator><creator>Vasconcelos Dos Santos, Thiago</creator><creator>Ramos, Patrícia Karla</creator><creator>Lima, Luciana Vieira</creator><creator>Campos, Marliane Batista</creator><creator>Silveira, Fernando Tobias</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240927</creationdate><title>Antigenic reactivity of Leishmania (Viannia) lainsoni axenic amastigote proved to be a suitable alternative for optimizing Montenegro skin test</title><author>de Melo, Leonardo Viana ; Vasconcelos Dos Santos, Thiago ; Ramos, Patrícia Karla ; Lima, Luciana Vieira ; Campos, Marliane Batista ; Silveira, Fernando Tobias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-b642b5f9b1ba07630c50513c643e2b7a81a794d11b8d32d8b7a883366d23beba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antigen-antibody reactions</topic><topic>antigens</topic><topic>Antigens, Protozoan - immunology</topic><topic>Axenic amastigote antigen</topic><topic>Axenic promastigote antigen</topic><topic>Brazil</topic><topic>cell-mediated immunity</topic><topic>cutaneous leishmaniasis</topic><topic>delayed hypersensitivity</topic><topic>Diagnosis</topic><topic>Evaluation</topic><topic>Female</topic><topic>Humans</topic><topic>Laboratory diagnosis</topic><topic>Leishmania</topic><topic>Leishmania (V.) braziliensis</topic><topic>Leishmania (V.) lainsoni</topic><topic>Leishmania - immunology</topic><topic>Leishmaniasis</topic><topic>Leishmaniasis, Cutaneous - diagnosis</topic><topic>Leishmaniasis, Cutaneous - immunology</topic><topic>Leishmaniasis, Cutaneous - parasitology</topic><topic>Male</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Montenegro skin test</topic><topic>parasites</topic><topic>Physiological aspects</topic><topic>Skin tests</topic><topic>Skin Tests - methods</topic><topic>t-test</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Melo, Leonardo Viana</creatorcontrib><creatorcontrib>Vasconcelos Dos Santos, Thiago</creatorcontrib><creatorcontrib>Ramos, Patrícia Karla</creatorcontrib><creatorcontrib>Lima, Luciana Vieira</creatorcontrib><creatorcontrib>Campos, Marliane Batista</creatorcontrib><creatorcontrib>Silveira, Fernando Tobias</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Parasites &amp; vectors</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Melo, Leonardo Viana</au><au>Vasconcelos Dos Santos, Thiago</au><au>Ramos, Patrícia Karla</au><au>Lima, Luciana Vieira</au><au>Campos, Marliane Batista</au><au>Silveira, Fernando Tobias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antigenic reactivity of Leishmania (Viannia) lainsoni axenic amastigote proved to be a suitable alternative for optimizing Montenegro skin test</atitle><jtitle>Parasites &amp; vectors</jtitle><addtitle>Parasit Vectors</addtitle><date>2024-09-27</date><risdate>2024</risdate><volume>17</volume><issue>1</issue><spage>402</spage><epage>402</epage><pages>402-402</pages><artnum>402</artnum><issn>1756-3305</issn><eissn>1756-3305</eissn><abstract>Laboratory diagnosis of American cutaneous leishmaniasis (ACL) requires a tool amenable to the epidemiological status of ACL in Brazil. Montenegro skin test (MST), an efficient immunological tool used for laboratory diagnosis of ACL, induces delayed-type hypersensitivity (DTH) response to the promastigote antigens of Leishmania; however, human immune responses against infection are modulated by the amastigote of the parasite. Leishmania (V.) lainsoni induces strong cellular immunity in humans; therefore, the antigenic reactivity of its axenic amastigote (AMA antigen) to MST was evaluated for the laboratory diagnosis of ACL. Among 70 individuals examined, 60 had a laboratory-confirmed diagnosis of ACL; 53 had localized cutaneous leishmaniasis (LCL), and 7 had mucosal leishmaniasis (ML). Patients were treated at the Evandro Chagas Institute's leishmaniasis clinic, Pará State, Brazil. Ten healthy individuals with no history of ACL (control group) were also examined. Leishmania (V.) braziliensis promastigote antigen (PRO) was used to compare the reactivity with that of AMA antigen. Paired Student's t-test, kappa agreement, and Spearman test were used to evaluate the reactivity of AMA and PRO. The mean reactivity of AMA in ACL patients was 19.4 mm ± 13.3, which was higher (P &lt; 0.001) than that of PRO: 12.1 mm ± 8.1. MST reactivity according to the clinical forms revealed that AMA reactivity in LCL and ML, 18.8 mm ± 13.3 and 24.3 mm ± 13.7, was higher (P &lt; 0.001) than that of PRO, 11.8 mm ± 8.2 and 14.6 mm ± 8.4, respectively. AMA reactivity was higher than that of PRO, indicating that AMA is a promising alternative for optimizing MST in the laboratory diagnosis of ACL.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>39334233</pmid><doi>10.1186/s13071-024-06486-0</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1756-3305
ispartof Parasites & vectors, 2024-09, Vol.17 (1), p.402-402, Article 402
issn 1756-3305
1756-3305
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a0c6d2d7559f419d8edcb3fa10184e0a
source Publicly Available Content (ProQuest); PubMed Central
subjects Adolescent
Adult
Antigen-antibody reactions
antigens
Antigens, Protozoan - immunology
Axenic amastigote antigen
Axenic promastigote antigen
Brazil
cell-mediated immunity
cutaneous leishmaniasis
delayed hypersensitivity
Diagnosis
Evaluation
Female
Humans
Laboratory diagnosis
Leishmania
Leishmania (V.) braziliensis
Leishmania (V.) lainsoni
Leishmania - immunology
Leishmaniasis
Leishmaniasis, Cutaneous - diagnosis
Leishmaniasis, Cutaneous - immunology
Leishmaniasis, Cutaneous - parasitology
Male
Methods
Middle Aged
Montenegro skin test
parasites
Physiological aspects
Skin tests
Skin Tests - methods
t-test
Young Adult
title Antigenic reactivity of Leishmania (Viannia) lainsoni axenic amastigote proved to be a suitable alternative for optimizing Montenegro skin test
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T14%3A40%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antigenic%20reactivity%20of%20Leishmania%20(Viannia)%20lainsoni%20axenic%20amastigote%20proved%20to%20be%20a%20suitable%20alternative%20for%20optimizing%20Montenegro%20skin%20test&rft.jtitle=Parasites%20&%20vectors&rft.au=de%20Melo,%20Leonardo%20Viana&rft.date=2024-09-27&rft.volume=17&rft.issue=1&rft.spage=402&rft.epage=402&rft.pages=402-402&rft.artnum=402&rft.issn=1756-3305&rft.eissn=1756-3305&rft_id=info:doi/10.1186/s13071-024-06486-0&rft_dat=%3Cgale_doaj_%3EA810404697%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-b642b5f9b1ba07630c50513c643e2b7a81a794d11b8d32d8b7a883366d23beba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3110906762&rft_id=info:pmid/39334233&rft_galeid=A810404697&rfr_iscdi=true